vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and Ibotta, Inc. (IBTA). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $88.5M, roughly 1.1× Ibotta, Inc.). On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs -10.0%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 3.7%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Ibotta, Inc. is an American mobile technology company headquartered in Denver, Colorado. Founded in 2011, the company offers cash back rewards on various purchases through its Ibotta Performance Network and direct to consumer app. Ibotta partners with CPG brands and network publishers to provide these rewards. As of 2024, the company operates solely in the United States. The company's rewards-as-a-service offering, the Ibotta Performance Network, went live in 2022.

HIVE vs IBTA — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.1× larger
HIVE
$93.1M
$88.5M
IBTA
Growing faster (revenue YoY)
HIVE
HIVE
+228.6% gap
HIVE
218.6%
-10.0%
IBTA
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
3.7%
IBTA

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
IBTA
IBTA
Revenue
$93.1M
$88.5M
Net Profit
$-91.3M
Gross Margin
-27.1%
78.7%
Operating Margin
-1.9%
Net Margin
-98.1%
Revenue YoY
218.6%
-10.0%
Net Profit YoY
-234.0%
EPS (diluted)
$-0.38
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
IBTA
IBTA
Q4 25
$93.1M
$88.5M
Q3 25
$87.3M
$83.3M
Q2 25
$45.6M
$86.0M
Q1 25
$84.6M
Q4 24
$29.2M
$98.4M
Q3 24
$22.6M
$98.6M
Q2 24
$32.2M
$87.9M
Q1 24
$82.3M
Net Profit
HIVE
HIVE
IBTA
IBTA
Q4 25
$-91.3M
Q3 25
$-15.8M
$1.5M
Q2 25
$35.0M
$2.5M
Q1 25
$555.0K
Q4 24
$68.2M
Q3 24
$80.0K
$17.2M
Q2 24
$-18.3M
$-34.0M
Q1 24
$9.3M
Gross Margin
HIVE
HIVE
IBTA
IBTA
Q4 25
-27.1%
78.7%
Q3 25
4.7%
79.4%
Q2 25
-13.6%
79.2%
Q1 25
79.8%
Q4 24
-43.7%
84.6%
Q3 24
-66.1%
87.7%
Q2 24
-7.4%
86.0%
Q1 24
87.2%
Operating Margin
HIVE
HIVE
IBTA
IBTA
Q4 25
-1.9%
Q3 25
2.8%
Q2 25
1.4%
Q1 25
-3.3%
Q4 24
13.2%
Q3 24
21.0%
Q2 24
-24.6%
Q1 24
19.3%
Net Margin
HIVE
HIVE
IBTA
IBTA
Q4 25
-98.1%
Q3 25
-18.1%
1.8%
Q2 25
76.8%
2.9%
Q1 25
0.7%
Q4 24
233.2%
Q3 24
0.4%
17.5%
Q2 24
-56.7%
-38.6%
Q1 24
11.3%
EPS (diluted)
HIVE
HIVE
IBTA
IBTA
Q4 25
$-0.38
$-0.03
Q3 25
$-0.07
$0.05
Q2 25
$0.18
$0.08
Q1 25
$0.02
Q4 24
$0.52
$3.04
Q3 24
$0.00
$0.51
Q2 24
$-0.17
$-1.32
Q1 24
$0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
IBTA
IBTA
Cash + ST InvestmentsLiquidity on hand
$186.6M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$559.3M
$287.7M
Total Assets
$624.0M
$525.9M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
IBTA
IBTA
Q4 25
$186.6M
Q3 25
$223.3M
Q2 25
$250.5M
Q1 25
$297.1M
Q4 24
$40.5M
$349.3M
Q3 24
$31.7M
$341.3M
Q2 24
$317.9M
Q1 24
$79.5M
Total Debt
HIVE
HIVE
IBTA
IBTA
Q4 25
$0
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
$0
Q2 24
$0
Q1 24
$65.3M
Stockholders' Equity
HIVE
HIVE
IBTA
IBTA
Q4 25
$559.3M
$287.7M
Q3 25
$624.6M
$329.6M
Q2 25
$560.5M
$354.1M
Q1 25
$401.3M
Q4 24
$430.9M
$457.3M
Q3 24
$275.5M
$378.0M
Q2 24
$268.6M
$359.7M
Q1 24
$44.1M
Total Assets
HIVE
HIVE
IBTA
IBTA
Q4 25
$624.0M
$525.9M
Q3 25
$693.0M
$569.4M
Q2 25
$628.7M
$600.8M
Q1 25
$639.3M
Q4 24
$478.6M
$678.4M
Q3 24
$334.7M
$598.3M
Q2 24
$556.0M
Q1 24
$322.1M
Debt / Equity
HIVE
HIVE
IBTA
IBTA
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
1.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
IBTA
IBTA
Operating Cash FlowLast quarter
$46.0M
$27.8M
Free Cash FlowOCF − Capex
$20.3M
FCF MarginFCF / Revenue
22.9%
Capex IntensityCapex / Revenue
8.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$75.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
IBTA
IBTA
Q4 25
$46.0M
$27.8M
Q3 25
$-10.6M
$21.8M
Q2 25
$10.2M
$25.9M
Q1 25
$19.9M
Q4 24
$-28.5M
$22.0M
Q3 24
$-2.2M
$39.5M
Q2 24
$-4.4M
$35.0M
Q1 24
$19.4M
Free Cash Flow
HIVE
HIVE
IBTA
IBTA
Q4 25
$20.3M
Q3 25
$14.5M
Q2 25
$22.2M
Q1 25
$18.0M
Q4 24
$-55.5M
$21.8M
Q3 24
$-34.7M
$39.2M
Q2 24
$34.8M
Q1 24
$19.2M
FCF Margin
HIVE
HIVE
IBTA
IBTA
Q4 25
22.9%
Q3 25
17.4%
Q2 25
25.8%
Q1 25
21.2%
Q4 24
-189.9%
22.1%
Q3 24
-153.4%
39.8%
Q2 24
39.6%
Q1 24
23.3%
Capex Intensity
HIVE
HIVE
IBTA
IBTA
Q4 25
8.5%
Q3 25
8.7%
Q2 25
4.2%
Q1 25
2.2%
Q4 24
92.5%
0.2%
Q3 24
143.9%
0.3%
Q2 24
0.2%
Q1 24
0.2%
Cash Conversion
HIVE
HIVE
IBTA
IBTA
Q4 25
Q3 25
14.19×
Q2 25
0.29×
10.38×
Q1 25
35.78×
Q4 24
-0.42×
Q3 24
-26.94×
2.29×
Q2 24
Q1 24
2.08×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIVE
HIVE

Segment breakdown not available.

IBTA
IBTA

Redemption Revenue$78.5M89%
Ad Other Revenue$10.0M11%
Breakage$2.1M2%

Related Comparisons